Exosomes have emerged as potential therapeutic vectors for repair of non-healing wounds, which continue to be a significant source of morbidity and represent a substantial financial burden to patients and health care systems in general. However, the therapeutic potency ? and thus the translational potential ? of exosomes for wound repair is limited, as exosomes contain low amounts of nucleic acid cargo, such as microRNAs (miRNAs), which are critical to defining exosome bioactivity. Towards overcoming this limitation, we have developed a novel ethanol conditioning approach for endothelial cell-derived exosomes. This method reduces anti- angiogenic miRNA cargo and increases pro-angiogenic long non-coding RNA cargo in these exosomes, leading to an overall increase in angiogenic bioactivity. Angiogenic dysfunction is a hallmark of non-healing wounds, thus these enhanced exosome formulations have therapeutic potential in wound repair. Our team of bioengineers and clinicians will test approaches to further exert control over endothelial exosome non-coding RNA cargo and bioactivity via environmental conditioning approaches (Aim 1) and exogenous loading techniques (Aim 2). We will further test the therapeutic efficacy of enhanced exosomes in excisional, diabetic, and burn injury wound repair models (Aim 3) to identify the most promising avenue for further translational investigations. Overall, these studies will promote the development of a new class of therapeutics for non-healing wounds that could benefit millions of patients.

Public Health Relevance

Exosomes have shown promise as therapeutic vectors for wound healing and other applications. However, low non-coding RNA levels within exosomes may limit their therapeutic potency and prevent clinical translation. The overall goal of this application is to leverage newly developed approaches to control non-coding RNA in endothelial cell-derived exosomes by environmental conditioning and exogenous loading to increase therapeutic efficacy in wound repair.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Gene and Drug Delivery Systems Study Section (GDD)
Program Officer
Luo, James
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Maryland College Park
Biomedical Engineering
Biomed Engr/Col Engr/Engr Sta
College Park
United States
Zip Code
Patel, Divya B; Luthers, Christopher R; Lerman, Max J et al. (2018) Enhanced extracellular vesicle production and ethanol-mediated vascularization bioactivity via a 3D-printed scaffold-perfusion bioreactor system. Acta Biomater :
Lamichhane, Tek N; Jay, Steven M (2018) Production of Extracellular Vesicles Loaded with Therapeutic Cargo. Methods Mol Biol 1831:37-47
Patel, Divya B; Santoro, Marco; Born, Louis J et al. (2018) Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment. Biotechnol Adv 36:2051-2059